AC
TFFP

Aristides Capital’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Aristides Capital’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-546
Closed -$121K – 306
2021
Q4 		$121K Buy
+546
New +$106K 0.06% 235

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Aristides Capital's TFFP Position: Q1 2022 in Review

Aristides Capital sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2022, closing a stake of 546 shares — an estimated $121K sold.

Aristides Capital first reported a position in TFFP in Q4 2021 and held it in 1 quarter. The position peaked at $121K in Q4 2021. 43 funds tracked by Wall St. Rank hold TFFP as of Q1 2022.

  • Aristides Capital reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Aristides Capital sold 546 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $121K.
  • Aristides Capital first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Aristides Capital's TFF Pharmaceuticals, Inc. Common Stock position peaked at $121K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.